Cytosorbents (CTSO) Research & Development (2010 - 2026)
Cytosorbents' (CTSO) quarterly Research & Development came in at $1.0 million in Q1 2026, down 38.36% YoY from $1.7 million in Q1 2025, and down 38.36% on a QoQ basis from $1.7 million in Q1 2025.
Cytosorbents (CTSO) Research & Development (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Research & Development data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Research & Development fell 38.36% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 11.26% YoY) and the FY2025 annual result came in at $3.4 million, down 32.18% from the prior year.
- Research & Development retreated to $1.0 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $4.2 million in Q1 2022 to a low of -$640040.0 in Q4 2024.
- A 5-year average of $2.8 million and a median of $3.3 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development soared 85.95% — and 2024, when it plunged 115.62%.
- Tracing CTSO's Research & Development over 5 years: stood at $3.4 million in 2022, then rose by 20.42% to $4.1 million in 2023, then plunged by 115.62% to -$640040.0 in 2024, then surged by 359.83% to $1.7 million in 2025, then slumped by 38.36% to $1.0 million in 2026.
- The last three Research & Development figures came in at $1.0 million (Q1 2026), $1.7 million (Q1 2025), and -$640040.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Cytosorbents | 23.59 Mn | 19.18 Mn | 7.05 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.45 Mn |
| Mar 31, 2026 | 1.03 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | -640,040.00 |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 2.25 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Sep 30, 2023 | 3.75 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Mar 31, 2023 | 4.21 Mn |
| Dec 31, 2022 | 3.40 Mn |
| Sep 30, 2022 | 3.29 Mn |
| Jun 30, 2022 | 4.18 Mn |
| Mar 31, 2022 | 4.24 Mn |
| Dec 31, 2021 | 6.14 Mn |
| Sep 30, 2021 | 4.26 Mn |
| Jun 30, 2021 | 3.70 Mn |
| Mar 31, 2021 | 2.28 Mn |
| Dec 31, 2020 | 2.69 Mn |